Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1089)
Regions
Africa (57)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (10)
Western Pacific (36)
Diseases
COVID-19 (1481)
Chikungunya (9)
Cholera (33)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (7)
Low (111)
Critically low (685)
Not applicable (274)
1481 results found
2025
∙
JCVI
JCVI statement on COVID-19 vaccination in autumn 2026 and spring 2027
2025
∙
Folkhälsomyndigheten
Recommendations for COVID-19 vaccination from September 1 2025 in Sweden
2025
∙
Health Council of the Netherlands
COVID-19 vaccination in 2025 in the Netherlands
2025
∙
ATAGI
ATAGI statement on the administration of COVID-19 vaccines in 2025
2025
∙
CAVEI
CAVEI recommendation on annual vaccination against COVID-19 for the year 2025
2025
∙
NACI
Guidance on the use of COVID-19 vaccines for 2025 to summer 2026
2024
∙
Nangsue, C. Srisurapanont, K. Sudjaritruk, T.
A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis
2024
∙
Wang, F. Gao, Y. Wagner, A. L. Lu, Y.
A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination
2024
∙
Song, S. Madewell, Z. J. Liu, M. Miao, Y. Xiang, S. Huo, Y. Sarkar, S. Chowdhury, A. Longini, I. M. Yang, Y.
A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants
2024
∙
Gray, A. Alemohammad, S. Y. Ramirez-Ortiz, D. Trepka, M. J.
A Systematic Review of Factors Associated with COVID-19 Vaccine Uptake, Hesitancy, and Acceptability Among Adults with HIV: Implications for Integrating COVID-19 Immunization into HIV Care
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register